<SEC-DOCUMENT>0001193125-22-192325.txt : 20220713
<SEC-HEADER>0001193125-22-192325.hdr.sgml : 20220713
<ACCEPTANCE-DATETIME>20220713075301
ACCESSION NUMBER:		0001193125-22-192325
CONFORMED SUBMISSION TYPE:	SC 14D9/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220713
DATE AS OF CHANGE:		20220713

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 14D9/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-32384
		FILM NUMBER:		221080208

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 14D9/A

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 14D9/A
<SEQUENCE>1
<FILENAME>d324523dsc14d9a.htm
<DESCRIPTION>SC 14D9/A
<TEXT>
<HTML><HEAD>
<TITLE>SC 14D9/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE <FONT
STYLE="white-space:nowrap">14D-9</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Rule <FONT STYLE="white-space:nowrap">14d-101)</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SOLICITATION/RECOMMENDATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;3) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Subject Company) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Statement) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK,
PAR VALUE $0.001 PER SHARE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Title of Class&nbsp;of Securities) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>88338N206 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(CUSIP Number
of Class&nbsp;of Securities) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Hugh O&#146;Dowd </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>951
Yamato Road, Suite 220 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, FL 33431 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (561) <FONT STYLE="white-space:nowrap">961-1900</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing Statement)
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>With copies to: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Marlan Walker</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>General Counsel</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD, Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>951
Yamato Road, Suite 220</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boca Raton, FL 33431</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (561) <FONT STYLE="white-space:nowrap">961-1900</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joshua M. Samek, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>J.A. Glaccum, Esq.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DLA
Piper LLP (US)</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>200 South Biscayne Boulevard, Suite 2500</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Miami, Florida 33131</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (305) <FONT STYLE="white-space:nowrap">423-8500</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Check the box if the filing relates solely to preliminary communications made before the commencement of a tender
offer. </P></TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;3 (this &#147;<I>Amendment</I>&#148;) to
<FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9&nbsp;amends</FONT> and supplements the Solicitation / Recommendation Statement on <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9&nbsp;previously</FONT> filed by TherapeuticsMD, Inc., a
Nevada corporation (the &#147;<I>Company</I>,&#148; &#147;<I>TherapeuticsMD</I>,&#148; &#147;<I>we</I>,&#148; &#147;<I>our</I>&#148; or &#147;<I>us</I>&#148;), with the Securities and Exchange Commission on June&nbsp;13, 2022 (as amended on
June&nbsp;29, 2022 and July&nbsp;6, 2022, the &#147;<I>Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT></I>&#148;), relating to the cash tender offer by Athene Merger Sub, Inc. (&#147;<I>Merger Sub</I>&#148;), a Nevada corporation and
wholly-owned subsidiary of Athene Parent, Inc., a Nevada Corporation (&#147;<I>Parent</I>&#148;), to purchase all of the issued and outstanding shares of the Company&#146;s common stock, par value $0.001 per share (the &#147;<I>Shares</I>&#148;), at
a purchase price of $10.00 per Share, net to the seller in cash, without interest, and subject to withholding taxes, upon the terms and subject to the conditions set forth in the Agreement and Plan of Merger, dated as of May&nbsp;27, 2022, by and
among the Company, Parent and Merger Sub, the Offer to Purchase, dated as of June&nbsp;6, 2022 and the related Letter of Transmittal, each of which may be amended or supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise set forth in this Amendment, the information set forth in the <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9&nbsp;remains</FONT>
unchanged and is incorporated herein by reference to the extent relevant to the items in this Amendment. Capitalized terms used but not defined herein have the meanings ascribed to them in the
<FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Item&nbsp;8. Additional Information. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8 of the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> is hereby amended and supplemented by adding the following paragraphs as a new
subsection following the heading entitled &#147;Item 8. Additional Information &#150; Extension of the Offer&#148; on page 46: </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration of the
Offer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer and withdrawal rights expired as scheduled at one minute after 11:59&nbsp;p.m., New York City time, on July&nbsp;12, 2022 and was not
extended. The Depositary and Paying Agent of Parent has indicated that, as of the Expiration Date, approximately 2,705,915 Shares have been validly tendered and not properly withdrawn pursuant to the Offer, representing approximately 30.6% of the
outstanding Shares. As a result, the Minimum Condition was not satisfied and no Shares were accepted for payment or paid for pursuant to the Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
press release of the Company announcing the expiration and results of the Offer is attached as Exhibit&nbsp;(a)(5)(E) to this Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> and is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9. </B><B><I>Exhibits.</I></B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9 of the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> is hereby amended by inserting the following Exhibit below (a)(5)(D) as Exhibit
(a)(5)(E). </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a)(5)(E)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d324523dex99a5e.htm">Press Release issued by the Company, dated July&nbsp;13, 2022. </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: July&nbsp;13, 2022 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THERAPEUTICSMD, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marlan D. Walker</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Marlan D. Walker</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: General Counsel and Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(5)(E)
<SEQUENCE>2
<FILENAME>d324523dex99a5e.htm
<DESCRIPTION>EX-99.(A)(5)(E)
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.(a)(5)(E)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (a)(5)(E) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g324523g04p12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR IMMEDIATE RELEASE</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD Announces Expiration of Tender Offer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Company anticipates termination of Merger Agreement with EW Healthcare Partners </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BOCA RATON, Fla.</B><B></B><B>&nbsp;&#150; July</B><B></B><B>&nbsp;13, 2022</B> &#150; TherapeuticsMD, Inc. (NASDAQ: TXMD), (&#147;TXMD&#148; or the
&#147;Company&#148;) an innovative, leading women&#146;s healthcare company, announced today that Athene Merger, Inc., an affiliate of EW Healthcare Partners (&#147;EW&#148;), did not acquire the required majority of shares of TXMD through the
previously announced tender offer by the extended offer deadline of one minute after 11:59 PM Eastern Time on July&nbsp;12, 2022. As a result, the tender offer has expired according to its terms. The Company anticipates that the Merger Agreement
between TXMD and EW will be terminated pursuant to its terms following 11:59 PM Eastern Time on July&nbsp;13, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD intends to maintain
normal operations at this time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TherapeuticsMD Advisors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Greenhill&nbsp;&amp; Co., LLC is serving as financial advisor and DLA Piper LLP (US) and Jones Day are serving as legal counsel to TherapeuticsMD. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About TherapeuticsMD, Inc.</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD, Inc. is an
innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. TherapeuticsMD&#146;s products are designed to address the unique changes and challenges women experience through the various
stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. TherapeuticsMD is committed to advancing the health of women and championing awareness of their healthcare issues. To learn more about
TherapeuticsMD, please visit <U>https://www.therapeuticsmd.com/</U> or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Notes Regarding Forward Looking Statements</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statements in this communication, including, without limitation, statements regarding the proposed transaction, plans and objectives, and
management&#146;s beliefs, expectations or opinions, may contain forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and often
address expected future actions and expected future business and financial performance. Forward-looking statements may be identified by the use of words such as &#147;believe,&#148; &#147;will,&#148; &#147;should,&#148; &#147;estimate,&#148;
&#147;anticipate&#148;, &#147;potential,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;may,&#148; &#147;subject to,&#148; &#147;continues,&#148; &#147;if&#148; and similar words and phrases. These forward-looking statements
are not guarantees of future events and involve risks, uncertainties and assumptions that are difficult to predict.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Actual results, developments and
business decisions may differ materially from those expressed or implied in any forward-looking statements as a result of numerous factors, risks and uncertainties over which the Company has no control. These factors, risks and uncertainties
include, but are not limited to, the following: whether the Company will be able to repay the indebtedness under the Company&#146;s Financing Agreement, which is scheduled to mature on July&nbsp;13, 2022, and, if not, whether the Company will be
able to continue as a going concern; risks that the failure of the proposed transaction disrupts current plans and operations and potential difficulties in employee retention as a result of the failure of the proposed transaction; risks related to
diverting management&#146;s attention from ongoing business operations; the outcome of any legal proceedings that may be instituted related to the proposed transaction or the transaction agreement between the parties to the proposed transaction; the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount of the costs, fees, expenses and other charges related to the proposed transaction; general economic conditions, particularly those in the life science and medical device industries; stock
trading prices, including the impact of the failure of the proposed transaction on the Company&#146;s stock price, particularly in relation to the Company&#146;s current and future capital needs and its ability to raise additional funds to finance
its future operations; and other factors discussed from time to time in the reports of the Company filed with the Securities and Exchange Commission (the &#147;SEC&#148;), including the risks and uncertainties contained in the sections titled
&#147;Risk Factors&#148; and &#147;Cautionary Note Regarding Forward-Looking Statements&#148; in the Company&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as filed with the SEC on March&nbsp;23, 2022, and
related sections in the Company&#146;s subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> all of which are available free of charge at
http://www.sec.gov or under the &#147;Investors&nbsp;&amp; Media&#148; section on the Company&#146;s website at www.therapeuticsmd.com.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking
statements reflect the views and assumptions of management as of the date of this communication with respect to future events. The Company does not undertake, and hereby disclaims, any obligation, unless required to do so by applicable laws, to
update any forward-looking statements as a result of new information, future events or other factors. The inclusion of any statement in this communication does not constitute an admission by the Company or any other person that the events or
circumstances described in such statement are material.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lisa M. Wilson</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">In-Site</FONT>
Communications, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-452-2793</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">lwilson@insitecony.com</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TherapeuticsMD</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">561-961-1900</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IR@TherapeuticsMD.com</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g324523g04p12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g324523g04p12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1]L4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0'+            *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #O_XU  (  @.__C4  @ ".$))300F
M       .             #^    X0DE-! T       0   !X.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       ".$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9
MF@ &       ! #(    ! %H    &       ! #4    ! "T    &       !
M.$))30/X      !P  #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@  #A"24T$"
M$     $   )    "0      X0DE-!!X       0     .$))300:      ,U
M    !@              8@   SX          0
M   !              ,^    8@                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    8@    !29VAT;&]N9P   SX    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   &(     4F=H=&QO;F<   ,^     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    $.$))300,     !32     0   *     3
M   !X   (Z   !2V !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"
M$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-2
M1T(               $  /;6  $     TRU(4" @
M                                           18W!R=    5     S
M9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@   A@
M   49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD9
M L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A
M<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,
M8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T
M="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M
M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                 %A96B
M  #S40 !     1;,6%E:(                     !865H@        ;Z(
M #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A
MML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                9&5S8P         N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="                             &1E<V,         +%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                                  !V:65W       3I/X %%\N !#/
M%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M     0                        */     G-I9R      0U)4(&-U<G8
M       $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9
M %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8
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M0Q-C$X,3I!,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MP1TC">&&O:^1OW^U)L5AK:U<UC9'E@C/I<K%9Y#,542A@>322)R\*KB,,0K
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M>5C3"03\P)48Z4,\IIYQ:>W8^WW1G[PC%K*6)%B=)$5>$2>I&P9&9(D17*L
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AN3B6THW[!90!]-;Z8W&,8_+&,?P^GI1U:=?O7W7W7__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
